Pharma Industry News Weekly Recap: September 1, 2023
// Biotech and Pharma Therapeutics BMS publishes 'modest' multiple myeloma survival data on heir to Revlimid, Pomalyst August 30, [...]
// Biotech and Pharma Therapeutics BMS publishes 'modest' multiple myeloma survival data on heir to Revlimid, Pomalyst August 30, [...]
// Biotech and Pharma Therapeutics Takeda, Denali drop Alzheimer's asset after phase 1 peak reveals 'narrow therapeutic window' [...]
// Biotech and Pharma Therapeutics ProQR draws line under its eye disease era, offloading 2 assets to Théa [...]
// Biotech and Pharma Therapeutics Pfizer drops sickle cell disease collab with Syros inherited from GBT takeover July [...]
// Biotech and Pharma Therapeutics Obesity drug shortage expands to Saxenda as Novo Nordisk warns of limited supply for [...]
// Biotech and Pharma Therapeutics AbbVie sends SHP2 deal back to port, following Big Pharma peer in retreating [...]
// Biotech and Pharma Therapeutics Pfizer's Litfulo enters the scene in alopecia with adolescent nod to rival Lilly's [...]